<DOC>
	<DOCNO>NCT00147277</DOCNO>
	<brief_summary>The purpose study estimate quantify difference efficacy two sequence ATP therapy ( burst 15 pulse , 88 % versus burst 8 pulse , 88 % ) episode spontaneous rhythm classify fast ventricular tachycardia ( FVT ) via ventricular fibrillation ( VF ) patient Class I II A indication ICD implantation , thus promote `` painless '' therapy aspect ICD treatment improve quality life outcomes patient .</brief_summary>
	<brief_title>ADVANCE-D : Antitachycardia Pacing ( ATP ) Delivery Painless Implantable Cardioverter Defibrillator ( ICD ) Therapy</brief_title>
	<detailed_description>Main objective : Compare &amp; quantify efficacy two different sequence burst ATP strategy termination ventricular tachycardia ( Cycle Lenght ( CL ) 240ms-320ms ) baseline 12 month post randomisation patient treat ATP -8 pulse , 88 % versus patient treat ATP -15 pulse , 88 % Secondary objective : - Estimate efficacy ATP successfully treat FVT episodes patient primary secondary prevention - Estimate acceleration rate degeneration ATP therapy treat spontaneous FVT episodes ATP 15 v 8 arm - Compare likelihood syncopal event associate spontaneous FVT episodes - Estimate percent reduction number shock deliver per patient treat spontaneous FVT episodes - Evaluate different possible predictor ATP success : VT rate , underlie disease , Anti-Arrhythmic Drugs ( AAD ) , infarct zone , etc .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>ICD indication ( Class III A ) accord guideline ( patient coronary artery disease [ CAD ] nonCAD primary secondary ICD prevention ) Patients implanted Medtronic Marquis family ICD capable ATP FVT via VF Patient 's life expectancy le 1 year due noncardiac chronic disease Patient heart transplant list expect &lt; 1 year Patient 's age le 18 year ICD replacement upgrade ( single chamber [ SC ] ICDÂ® dual chamber [ DC ] ICD ) Unwillingness inability provide write informed consent Enrollment , intention participate , another clinical study course study Inaccessibility followup study center Ventricular tachyarrhythmias associate reversible cause Brugada syndrome , long QT hypertrophic cardiomyopathy ( HCM ) patient Other electrical implantable device ( neurostimulators , etc . ) Mechanical tricuspid valve</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>ATP</keyword>
	<keyword>Thachy</keyword>
	<keyword>FVT</keyword>
</DOC>